KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other financing activities (2016 - 2025)

AbbVie (ABBV) has disclosed Other financing activities for 14 consecutive years, with $45.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 207.14% to $45.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $68.0 million, a 19.3% increase, with the full-year FY2025 number at $68.0 million, up 19.3% from a year prior.
  • Other financing activities was $45.0 million for Q4 2025 at AbbVie, up from -$8.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $75.0 million in Q2 2024 to a low of -$42.0 million in Q4 2024.
  • A 5-year average of $13.4 million and a median of $15.0 million in 2022 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 625.0% in 2022; the steepest drop was 650.0% in 2022.
  • AbbVie's Other financing activities stood at $2.0 million in 2021, then plummeted by 650.0% to -$11.0 million in 2022, then soared by 536.36% to $48.0 million in 2023, then plummeted by 187.5% to -$42.0 million in 2024, then surged by 207.14% to $45.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other financing activities are $45.0 million (Q4 2025), -$8.0 million (Q2 2025), and $31.0 million (Q1 2025).